A rationale and model for addressing tobacco dependence in substance abuse treatment
dc.contributor.author | Kimber Richter | en_US |
dc.contributor.author | Julia Arnsten | en_US |
dc.date.accessioned | 2009-05-05T16:16:06Z | |
dc.date.available | 2009-05-05T16:16:06Z | |
dc.date.issued | 2007-04-03 | en_US |
dc.identifier.citation | Kimber Richter;Julia Arnsten: A rationale and model for addressing tobacco dependence in substance abuse treatment. Subst Abuse Treat Prev Policy 2006, 1(1):23. | en_US |
dc.identifier.uri | http://hdl.handle.net/2271/618 | en_US |
dc.description.abstract | Most persons in drug treatment smoke cigarettes. Until drug treatment facilities systematically treat their patients' tobacco use, millions will flow through the drug treatment system, overcome their primary drug of abuse, but die prematurely from tobacco-related illnesses. This paper reviews the literature on the health benefits of quitting smoking for drug treatment patients, whether smoking causes relapse to other drug or alcohol abuse, the treatment of tobacco dependence, and good and bad times for quitting smoking among drug treatment patients. It also presents a conceptual model and recommendations for treating tobacco in substance abuse treatment, and provides references to internet and paper-copy tools and information for treating tobacco dependence. At present, research on tobacco treatment in drug treatment is in its infancy. Although few drug treatment programs currently offer formal services, many more will likely begin to treat nicotine dependence as external forces and patient demand for these services increases. In the absence of clear guidelines and attention to quality of care, drug treatment programs may adopt smoking cessation services based on cost, convenience, or selection criteria other than efficacy. Because research in this field is relatively new, substance abuse treatment professionals should adhere to the standards of care for the general population, but be prepared to update their practices with emerging interventions that have proven to be effective for patients in drug treatment. | en_US |
dc.language | en | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | BioMedCentral | en_US |
dc.relation.isversionof | http://www.substanceabusepolicy.com/content/1/1/23 | en_US |
dc.relation.hasversion | http://www.biomedcentral.com/content/pdf/1747-597X-1-23.pdf | en_US |
dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by/2.0 | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Biomedical Research | en_US |
dc.subject.mesh | Disease Models, Animal | en_US |
dc.subject.mesh | Evolution | en_US |
dc.subject.mesh | Genetic Variation | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Medicine | en_US |
dc.subject.mesh | Philosophy, Medical | en_US |
dc.subject.mesh | Selection (Genetics) | en_US |
dc.subject.mesh | Species Specificity | en_US |
dc.title | A rationale and model for addressing tobacco dependence in substance abuse treatment | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1186/1747-597X-1-23 | en_US |
dc.identifier.pmid | PMC17407602 | en_US |
dc.rights.accessrights | openAccess | en_US |
dc.date.captured | 2009-04-27 | en_US |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.